Home › NDC Lookup › RxCUI directory › RxCUI 211817

Carbamazepine 200 MG Oral Tablet [Epitol] — RxCUI 211817

RxNorm drug concept · Semantic branded drug
RxCUI 211817 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI211817
Official nameCarbamazepine 200 MG Oral Tablet [Epitol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEpitol 200 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Carbamazepine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats certain seizures in epilepsy and the severe facial nerve pain of trigeminal neuralgia. The brand Equetro is also used for manic or mixed episodes in bipolar I disorder. I...
  • Take it by mouth exactly as prescribed. Many forms are taken with meals, and extended-release forms are usually twice a day. Carbatrol and Equetro capsules can be opened onto soft...
  • Dizziness, drowsiness, unsteadiness, nausea and vomiting are most common, especially at the start. Be careful driving until you know how it affects you. Call your doctor if they do...
  • Call for any rash, blisters or mouth sores, especially with fever. Also report fever, sore throat, easy bruising or bleeding, yellow skin or eyes, swelling of the face or lips, or...
📖 Read our full Carbamazepine guide →

🕸️ Concept Web — How Carbamazepine 200 MG Oral Tablet [Epitol] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carbamazepine 200 MG Oral Tablet [Epitol] RxCUI 211817

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Carbamazepine 2002
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Epitol 203251
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carbamazepine Oral Tablet 371260
    • Carbamazepine Oral Product 1155760
    • Carbamazepine Pill 1155761
    • Carbamazepine Oral Tablet [Epitol] 367637
    • Epitol Oral Product 1167624
    • Epitol Pill 1167625
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carbamazepine 200 MG Oral Tablet SCD · 308979
  • Carbamazepine 200 MG SCDC · 315565
  • Carbamazepine Oral Tablet SCDF · 371260
  • Carbamazepine Oral Product SCDG · 1155760
  • Carbamazepine Pill SCDG · 1155761

Brand-Name Concepts

  • Carbamazepine 200 MG [Epitol] SBDC · 572150
  • Carbamazepine Oral Tablet [Epitol] SBDF · 367637
  • Epitol Oral Product SBDG · 1167624
  • Epitol Pill SBDG · 1167625
  • Epitol BN · 203251

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 211817 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-0090-01 100 TABLET in 1 BOTTLE (0093-0090-01) Epitol Teva Pharmaceuticals USA, Inc. 1990-09-30
Observed labelers: Teva Pharmaceuticals USA, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.1186
Range $0.1186–$0.1186 · middle 50% $0.1186–$0.1186 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.